newsfilter.io

Chris Austin

Showing 1–3 of 3 transcripts.

  1. Milken Institute57 min

    Advancing Health Technology and Innovation

    Jonathan Simons, Chris Austin, Annalisa Jenkins, Richard Merkin, Kim Nguyen, David Spetzler

    Leading innovators and policymakers are convening to redefine healthcare delivery through a convergence of genomic editing, artificial intelligence, and cross-disciplinary collaboration rather than incremental improvements. Key figures emphasize leveraging technologies like CRISPR and deep learning to bridge the massive translation gap between molecular discovery and patient treatment, with the goal of curing rare genetic disorders and democratizing precision oncology. The discussion outlines a strategic framework for the UAE to leapfrog legacy systems by deploying high-impact solutions such as organ-on-a-chip models and AI-driven diagnostics to transform untreatable conditions into manageable outcomes within the coming decade.

  2. Milken Institute1h 7m

    Precision Medicine, Custom Cures

    Margaret Anderson, Mike Polini, Jim Greenwood, George Church, Retta Berry, Chris Austin

    Led by former NIH Director Francis Collins and moderated by Margaret Anderson, a diverse panel of scientists, industry leaders, and patient advocates examined the critical gap between rapid advances in precision medicine sequencing and clinical deployment. While the discussion highlighted success stories like the Berry family's transition from a diagnostic odyssey to effective treatment and the rising adoption of gene therapies, it also exposed systemic bottlenecks in rare disease therapeutics, reimbursement models, and data silos that prevent timely translation of genetic discoveries into cures. The group concluded that realizing the full potential of this medical revolution requires structural healthcare reform, robust data-sharing frameworks, and a shift toward participatory medicine where patients actively drive their own health outcomes.

  3. Milken Institute1h 15m

    The Promise of the Bioscience Century

    Paul Irving, Mike Milken, Eric Cantor, Paul Chu, Jeff, Bernardo Zavala, Jr., Bernard Harris, Andy von Eschenbach, Peggy, Francis Collins, Chris Austin

    This event analyzes the critical role of bioscience in driving global economic growth and societal well-being while highlighting China's aggressive $308 billion investment program that threatens to surpass U.S. leadership. Panelists discuss strategic institutional responses, such as DARPA's high-risk research model and the FDA's regulatory innovations, which have accelerated breakthroughs in prosthetics, personalized medicine, and disease prevention. However, fiscal constraints and shifting global demographics necessitate sustained bipartisan funding to preserve the United States' status as a central hub for scientific innovation and global health security.